Rafferty Asset Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-18,428
| Closed | -$435K | – | 1101 |
|
|
2023
Q4 | $435K | Buy |
18,428
+8,004
| +77% | +$189K | ﹤0.01% | 1003 |
|
|
2023
Q3 | $155K | Buy |
+10,424
| New | +$155K | ﹤0.01% | 1064 |
|
|
2022
Q3 | – | Sell |
-27,810
| Closed | -$82K | – | 1279 |
|
|
2022
Q2 | $82K | Buy |
27,810
+3,768
| +16% | +$11.1K | ﹤0.01% | 1080 |
|
|
2022
Q1 | $75K | Sell |
24,042
-4,814
| -17% | -$15K | ﹤0.01% | 1191 |
|
|
2021
Q4 | $98K | Buy |
28,856
+2,108
| +8% | +$7.16K | ﹤0.01% | 1257 |
|
|
2021
Q3 | $98K | Buy |
+26,748
| New | +$98K | ﹤0.01% | 1229 |
|
|
2021
Q1 | – | Sell |
-17,061
| Closed | -$98K | – | 1174 |
|
|
2020
Q4 | $98K | Buy |
17,061
+5,707
| +50% | +$32.8K | ﹤0.01% | 1004 |
|
|
2020
Q3 | $82K | Buy |
+11,354
| New | +$82K | ﹤0.01% | 946 |
|
|
2019
Q4 | – | Sell |
-13,370
| Closed | -$68K | – | 912 |
|
|
2019
Q3 | $68K | Buy |
+13,370
| New | +$68K | ﹤0.01% | 797 |
|